Phase 2 Readout~quarter
Phase 2 Readout: disc-3405
- Company
- Disc Medicine, Inc. (IRON)
- Drug
- disc-3405
- Indication
- PV
Other upcoming events for IRON
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.